דואוטרב ישראל - עברית - Ministry of Health

דואוטרב

novartis israel ltd - timolol as maleate; travoprost - תמיסה לעין - travoprost 40 mcg/ml; timolol as maleate 5 mg/ml - timolol, combinations - timolol, combinations - decrease of intraocular pressure (iop) in patients with open angle glaucoma or ocular hypertension who are insufficiently responsive to topical beta-blockers or prostaglandin analogues.

מאקליבן 250 מג5 מל ישראל - עברית - Ministry of Health

מאקליבן 250 מג5 מל

novartis israel ltd - amoxicillin as trihydrate; clavulanic acid as potassium - אבקה להכנת תרחיף - clavulanic acid as potassium 62.5 mg / 5 ml; amoxicillin as trihydrate 250 mg / 5 ml - combinations of penicillins, incl. beta-lactamase inhibitors - for the treatment of lower respiratory tract infections, otitis media infections , sinusitis, acute pharyngitis, skin and soft tissues infection, and urinary tract infections, caused also by beta-lactamase producing organisms which are susceptible to amoxiclav-teva and are resistant to other beta-lactam antibiotics.

מאקליבן 500 מג ישראל - עברית - Ministry of Health

מאקליבן 500 מג

novartis israel ltd - amoxicillin as trihydrate; clavulanic acid as potassium - טבליה - amoxicillin as trihydrate 500 mg; clavulanic acid as potassium 125 mg - combinations of penicillins, incl. beta-lactamase inhibitors - for the treatment of lower respiratory tract infections, otitis media infections, sinusitis, acute pharyngitis, skin and soft tissues infection, and urinary tract infections, caused also by beta-lactamase producing organisms which are susceptible to amoxiclav-teva and are resistant to other beta-lactam antibiotics.

קונבניה וטרינרי ישראל - עברית - Ministry of Health

קונבניה וטרינרי

zoetis israel holding b.v., israel - cefovicin as sodium salt - אבקה וממס להכנת תמיסה להזרקה - cefovicin as sodium salt 80 mg/dose - dogs : for the treatment of skin and soft tissue infections including pyoderma wounds and abscesses associated with staphylococcus intermedius beta-haemolytic streptococci escherichia coli and/or pasteurella multocida. for the treatment of urinary tract infections associated with escherichia coli and/or proteus spp.as adjunctive treatment to mechanical or surgical periodontal therapy of severe infections of the gingival and periodontal tissues associated with porphyromonas spp. and prevotella spp. cats : for the treatment of skin and soft tissue abscesses and wounds associated with pasteurella multocida fusobacterium spp. bacteroides spp. prevotella oralis beta-haemolytic streptococci and/or staphylococcus intermedius. for the treatment of urinary tract infections associated with escherichia coli.

לומיגן ישראל - עברית - Ministry of Health

לומיגן

allergan israel ltd - bimatoprost - תמיסה לעין - bimatoprost 0.3 mg/ml - bimatoprost - bimatoprost - reduction of elevated intraocular pressure in chronic open angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).

פוסטר 1006 ישראל - עברית - Ministry of Health

פוסטר 1006

kamada ltd, israel - beclometasone dipropionate anhydrous; formoterol fumarate dihydrate - תמיסה לשאיפה - formoterol fumarate dihydrate 6 mcg/dose; beclometasone dipropionate anhydrous 100 mcg/dose - formoterol and beclometasone - beclometasone - foster is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting beta2-agonist) is appropriate:- patients not adequately controlled with inhaled corticosteroids and 'as needed' inhaled short-acting beta2-agonist or- patients already adequately controlled on both inhaled corticosteroids and long-acting beta2-agonists.

סימביקורט טורבוהלר 804.5 מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 804.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 80 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. note: symbicort turbuhaler 80/4.5 mcg/dose is not appropriate in patients with severe asthma.

סימביקורט טורבוהלר 1604.5 מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 1604.5 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 160 mcg/dose; formoterol fumarate 4.5 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - asthma symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents age 12 years and above where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequately controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. or - patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

סימביקורט טורבוהלר 3209  מקגמנה ישראל - עברית - Ministry of Health

סימביקורט טורבוהלר 3209 מקגמנה

astrazeneca (israel) ltd - budesonide micronized; formoterol fumarate - אבקה לשאיפה - budesonide micronized 320 mcg/dose; formoterol fumarate 9 mcg/dose - formoterol and budesonide - formoterol and other drugs for obstructive airway diseases - symbicort turbuhaler is indicated in the regular treatment of asthma in adults and adolescents (over the age of 12 years) where use of a combination (inhaled corticosteroid and long acting beta-agonist) is appropriate: - patients not adequaterly controlled with inhaled corticosteroids and " as needed" inhaled short acting beta2- agonists. - or patients already adequately controlled on both inhaled corticosteroids and long acting beta2- agonists. copd symptomatic treatment of patients with severe copd (fev1 < 50 % predicted normal) and a history of repeated exacerbations who have significant symptoms despite regular therapy with long-acting bronchodilators.

קלטרה תמיסה לשתייה ישראל - עברית - Ministry of Health

קלטרה תמיסה לשתייה

abbvie biopharmaceuticals ltd, israel - lopinavir; ritonavir - תמיסה (פומי) - ritonavir 20 mg/ml; lopinavir 80 mg/ml - ritonavir - ritonavir - kaletra is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.